Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "Zomig nasal 5 mg" (20)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Zolmitriptan (N02CC03) 20 products
WHO-DDD
DrugBank.ca
IP
CI
Zomig oro
6 Comprimé(s)
20.73
38.85
10 %
Comprimés orodispersibles: Zolmitriptanum 2.5 mg
Grünenthal Pharma AG
B / SL / SO
FB
G
IP
CI
Zomig oro
12 Comprimé(s)
36.37
55.80
10 %
Comprimés orodispersibles: Zolmitriptanum 2.5 mg
Grünenthal Pharma AG
B / SL / SO
FB
G
IP
CI
Zomig 2,5 mg
3 Comprimé(s)
10.96
28.30
10 %
Comprimés filmés: Zolmitriptanum 2.5 mg
Grünenthal Pharma AG
B / SL / SO
FB
G
IP
CI
Zomig 2,5 mg
6 Comprimé(s)
20.94
39.10
10 %
Comprimés filmés: Zolmitriptanum 2.5 mg
Grünenthal Pharma AG
B / SL / SO
FB
G
IP
CI
Zomig 2,5 mg
12 Comprimé(s)
36.37
55.80
10 %
Comprimés filmés: Zolmitriptanum 2.5 mg
Grünenthal Pharma AG
B / SL / SO
FB
G
IP
CI
Zolmitriptan Sandoz
2 Comprimé(s)
6.56
16.35
10 %
Comprimés orodispersibles: Zolmitriptanum 2.5 mg
Sandoz
Pharmaceuticals AG
●
B / SL / SG
FB
G
IP
CI
Zolmitriptan Sandoz
6 Comprimé(s)
18.85
36.95
10 %
Comprimés orodispersibles: Zolmitriptanum 2.5 mg
Sandoz
Pharmaceuticals AG
●
B / SL / SG
FB
G
IP
CI
Zolmitriptan Sandoz
12 Comprimé(s)
33.07
52.40
10 %
Comprimés orodispersibles: Zolmitriptanum 2.5 mg
Sandoz
Pharmaceuticals AG
●
B / SL / SG
FB
G
IP
CI
Zolmitriptan Spirig HC 2.5
2 Comprimé(s)
6.56
16.35
10 %
Comprimés orodispersibles: Zolmitriptanum 2.5 mg
Spirig HealthCare AG
●
B / SL / SG
FB
G
IP
CI
Zolmitriptan Spirig HC 2.5
6 Comprimé(s)
18.85
36.95
10 %
Comprimés orodispersibles: Zolmitriptanum 2.5 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Zolmitriptan Spirig HC 2.5
12 Comprimé(s)
33.07
52.40
10 %
Comprimés orodispersibles: Zolmitriptanum 2.5 mg
Spirig HealthCare AG
●
B / SL / SG
FB
G
IP
CI
Zolmitriptan Sandoz
3 Comprimé(s)
10.14
27.45
10 %
Comprimés filmés: Zolmitriptanum 2.5 mg
Sandoz
Pharmaceuticals AG
●
B / SL / SG
FB
G
IP
CI
Zolmitriptan Sandoz
6 Comprimé(s)
19.40
37.50
10 %
Comprimés filmés: Zolmitriptanum 2.5 mg
Sandoz
Pharmaceuticals AG
●
B / SL / SG
FB
G
IP
CI
Zolmitriptan Sandoz
12 Comprimé(s)
34.04
53.40
10 %
Comprimés filmés: Zolmitriptanum 2.5 mg
Sandoz
Pharmaceuticals AG
●
B / SL / SG
FB
G
IP
CI
Zolmitriptan Spirig HC 2.5
3 Comprimé(s)
10.14
27.45
10 %
Comprimés: Zolmitriptanum 2.5 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Zolmitriptan Spirig HC 2.5
6 Comprimé(s)
19.40
37.50
10 %
Comprimés: Zolmitriptanum 2.5 mg
Spirig HealthCare AG
●
B / SL / SG
FB
G
IP
CI
Zolmitriptan Spirig HC 2.5
12 Comprimé(s)
34.04
53.40
10 %
Comprimés: Zolmitriptanum 2.5 mg
Spirig HealthCare AG
●
B / SL / SG
FB
G
L
IP
CI
Zomig nasal 5 mg
2 unidose(s)
18.60
36.65
10 %
Spray nasale: Zolmitriptanum 5 mg
Grünenthal Pharma AG
B / SL
FB
G
L
IP
CI
Zomig nasal 5 mg
6 unidose(s)
55.79
77.10
10 %
Spray nasale: Zolmitriptanum 5 mg
Grünenthal Pharma AG
B / SL
FB
G
IP
CI
Zomig nasal 2.5 mg
2 unidose(s)
32.88
55.10
k.A.
Spray nasale: Zolmitriptanum 2.5 mg
Grünenthal Pharma AG
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
